# Resolute Integrity US Extended Length Sub-Study(RI US XL)

> **NCT01913600** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 56 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Resolute Integrity Stent

## Key facts

- **NCT ID:** NCT01913600
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-10
- **Final completion:** 2018-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913600, "Resolute Integrity US Extended Length Sub-Study(RI US XL)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01913600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*